Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2013
September 26, 2013 at 04:51 pm IST
Share
Advanced BioMedical Technologies, Inc. reported earnings results for the third quarter and nine months ended July 31, 2013. For the quarter, the company has posted net loss attributable to the common stockholders was $156,548, or $0 per share, compared to a net loss attributable to the common stockholders of $190,879, or $0 per share, for the same quarter ended July 31, 2012. Loss from operations was $113,226, compared to a loss from operations of $160,509, for the same quarter ended July 31, 2012.
For the nine months, the company has posted net loss attributable to the common stockholders of $470,375, or $0.01 loss per share, compared to a net loss attributable to the common stockholders of $550,442, or $0.01 loss per share, for the same period ended July 31, 2012. Loss from operations was $346,022, compared to a loss from operations of $464,291, for the same period ended July 31, 2012.
Advanced Biomedical Technologies, Inc. is engaged in the business of designing, developing, manufacturing, and marketing of biomaterial internal fixation devices. The Companyâs primary products include Polymer Osteosynthesis Devices made of a proprietary material compositing of polyamide 6 (PA6), hydroxyapatite (HA) and poly (methyl methacrylate-co-N-vinylpyrrolidone) (P(MMA-co-NVP)). These advanced materials are used in surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, and reconstructive dental procedures. Its PA Binding Wires are under clinical trials and its PA Mini-Screws are under animal test.
ADVANCED BIOMEDICAL TECHNOLOGIES, INC. 
